Cargando…
SARS-CoV-2: Challenges in Reconverting Diagnostic Laboratories to Combat the Pandemic
Coronavirus disease 2019 (COVID-19) was first detected in Mexico in February 2020. Even though health authorities did not perceive then the value of viral detection tests, we anticipated the demand for them. We set up to develop an expeditious severe acute respiratory syndrome coronavirus 2 (SARS-Co...
Autores principales: | Barrera Saldaña, Hugo Alberto, Rivera Santiago, Carolina, Rodríguez Palacios, Raúl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769709/ https://www.ncbi.nlm.nih.gov/pubmed/36314981 http://dx.doi.org/10.1128/spectrum.01477-22 |
Ejemplares similares
-
Prevalence and Clinical Significance of Residual or Reconverted Red Bone Marrow on Knee MRI
por: Vo, Minh Tu, et al.
Publicado: (2021) -
Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages
por: Pérez-López, Briza, et al.
Publicado: (2021) -
Pandemic SARS-CoV-2 laboratory preparedness in India: An opportunity beyond diagnostics
por: Dwibedi, Bhagirathi
Publicado: (2020) -
SARS-CoV-2: Combating Coronavirus Emergence
por: Graham, Rachel L., et al.
Publicado: (2020) -
Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2
por: Negi, Kriti, et al.
Publicado: (2023)